VANESSA HEIMBACH: Open Payments
NPI 1437113768 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$879 in 35 payments from 10 companies in 2025. Trend: 2023 $786 · 2024 $771 · 2025 $879
Food & beverage: $879
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $361 |
| GlaxoSmithKline, LLC. | 8 | $204 |
| Regeneron Healthcare Solutions, Inc. | 7 | $131 |
| Optinose US, Inc. | 3 | $70 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Amgen Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| PFIZER INC. | 1 | $14 |
Products named: DUPIXENT, NUCALA, Xhance, TEZSPIRE, VOQUEZNA, KEYTRUDA, LIBTAYO, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
